NLRP3 and osteoporosis: Abnormal activation of NLRP3‐mediated pyroptosis has been linked to the progression of inflammatory bone loss disorders such as osteoporosis, periprosthetic osteolysis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.